IDEX Biometrics ASA (IDEX) Earnings Call Transcript & Summary
May 23, 2023
Earnings Call Speaker Segments
Morten Opstad
executiveWelcome to this Annual General Meeting in IDEX Biometrics. My name is Morten Opstad, I am Chair of the company, and we'll open this Annual General Meeting. As usual, we have an electronically held general meeting. And we are at offices [indiscernible], where we have DNB and we have also [indiscernible]. In Oslo as well, we have Vince Graziani, who is actually attending after his presentation this morning, but he is at Arctic Securities and not in this room, but he will be online if there are any questions for him in -- related to the general meeting. So we will then attend to the notice and the agenda items. And under agenda item 1, we need to registerate who is participating, all shareholders and proxies and voting instructions. So [ Freddie ] from DNB, could you please give an overview of what we have of participating shares for the moment?
Unknown Attendee
attendeeYes. Thank you, Morten. I'm participating here today. We have a total of 6 log-ins, but there is one shareholder voting online, representing a shareholder and 3 proxies for a total of 855,575 shares. We have also had proxy to Chair of the Board for 167,105,848 shares. We have proxies with instructions to Chair of the Board for 203,317,825 shares. In sum, this is 371,279,248 shares represented, and this constitutes 31.76% of the company's share capital. Thank you.
Morten Opstad
executiveThank you, [ Freddie ]. And that is the numbers we will use throughout the general meeting. Then we also need to have elected a person to chair the meeting. And the proposal is that the undersigned, Morten Opstad will chair the meeting. And also a person to co-sign minutes, and my proposal is that Mr. [indiscernible] will co-sign the minutes together with me. So that is the proposal and agenda item #1, which we will then have a vote on. So please cast your votes on this agenda item #1. [Voting]
Unknown Attendee
attendeeWe have now closed the voting. First item is 100% in favor of the proposal. No votes against and no votes abstaining.
Morten Opstad
executiveThank you, [ Freddie ]. We then move to agenda item #2, which is approval of the notice and the agenda of the meeting. The notice has been sent out 3 weeks ahead, which is the requirement, and there are no proposals from the Board to amend anything on the agenda for the meeting. So the proposal is to approve the notice and the agenda in the way it has been sent out to the shareholders. So please cast your votes on agenda item #2. [Voting]
Unknown Attendee
attendeeAnd we have received the votes and now closed the voting. Results on agenda item #2 is also 100% in favor of the proposal. There are no votes against and no votes abstaining.
Morten Opstad
executiveThank you, [ Freddie ]. Agenda item #3, that is approval of the annual report and annual financial statements for 2022, which has been distributed according to what we can do today on electronic and put on the website and so on. Do we have any questions related to the annual report and the financial statements nothing from you either [ Eileen ]. No questions to the company.
Unknown Executive
executiveNo.
Morten Opstad
executiveThen we will move to voting on agenda item #3, and the proposal is then to approve the annual report and the financial statements for 2022, according to the notice. So please cast your votes. [Voting]
Unknown Attendee
attendeeAnd we have received the votes. Results on this agenda item #3 is also 100% in favor of the proposal. No votes against and no votes abstaining. Thank you.
Morten Opstad
executiveThank you, [ Freddie ]. Agenda Item #4, that is an advisory vote on the 2022 executive remuneration report, and the Board has then prepared a report on the salary and other remuneration of executive management of the company in 2022, and the Board represent the remuneration report to the AGM by an advisory vote. And the report has been put on the web. We will not go to that one, no. Has there been any questions and comments to the report?
Unknown Executive
executiveNo.
Morten Opstad
executiveThat's not the case. And what -- we then propose is that the Annual General Meeting approves the remuneration report for 2022 in this advisory votes. So please cast your votes. [Voting]
Unknown Attendee
attendeeAnd we have received the votes. Results from this agenda item #4 is 98.52% in favor of the proposal, 1.48% against and no shares abstaining.
Morten Opstad
executiveSo the executive remuneration report is approved. Then we go to agenda item #5, which is an authorization to the Board to issue new shares, and that is the standard authorization we are asking for at every general meeting, and that is a 10% authorization to the Board and that is according to the corporate governance regulations. It's split into 2, and that is on Board authorization to issues shares in the private placement and number [indiscernible] b, Board authorization to issue shares in the rights issue. So this is content of the proposed authorization is similar to previous years. Are there any questions or comments to that agenda item? That's not the case. And I will propose that we work both on a 5A and 5B at the same time. So please cast your votes with respect to agenda item #5 A and B. [Voting]
Unknown Attendee
attendeeAnd we have received the votes. Results on 5A is 99.999% in favor of the proposal. There are 12,400 shares voting against, and no votes abstaining. On 5B, we have 99.98% in favor of the proposal. 82,000 shares are voting against, representing 0.02%. No votes are abstaining.
Morten Opstad
executiveThank you, and then we move to agenda item #6, and that is also a proposal which is standard for the Annual General Meeting and that is the company's 2023 subscription rights incentive plan, and that is the action plan for the company, that is also limited to 10%, and the content of this one is also similar to what we have had previous years. So we have both the 2023 incentive plan, and then we have under agenda item 3, also the plan document itself, which needs to be approved by the general meeting due to certain tax regulations in the U.S., whereby that need shareholder approval. Has there been any questions related to the subscription rights plan proposal and the plan document itself? If that's not the case, then I think we will also here vote on 6.1 and 6.2 at the same time. So please cast your votes. [Voting]
Unknown Attendee
attendeeAnd we have closed the voting. We have 97.72% in favor on 6.1 -- sorry, and then 2.28% are against, no votes are abstaining. On 6.2, we have 97.72% in favor to proposal, 2.28% are voting against, and no shares are abstaining.
Morten Opstad
executiveThank you, [ Freddie ]. Then we move to agenda item #7, which is a proposal for the Board authorization to issue shares in accordance with what we call the 2023 employee share purchase plan, and also here, approval of the 2023 employee share purchase plan itself. This is a system whereby employees can use a certain portion of their salary and convert or buy shares for their salary at a certain discount in the share price. And the authorization is limited to 5%. And this is actually a system which has been used a lot from our U.S. -- especially from our U.S. employees and is a common system in the U.S.-based companies. So even if we have a Norwegian listed company, we have, as you all know, our activity in the U.S. and therefore, we introduced this system a few years ago. Also here, there is a split between 7.1, which is the share purchase plan itself with the limitation to 5%, and then we have the plan document in 7.2. Has there been any questions or comments to this proposal on the share purchase plan? If that's not the case, then we proceed with the voting. So please cast your votes under 7.1 and 7.2. Thank you. [Voting]
Unknown Attendee
attendeeAnd we have received the votes, and closed the voting. 7.1 has received 98.43% in favor of the proposal, 1.57% are against, and notes are abstaining. Results on 7.2 is 98.43% in favor of the proposal, 1.57% are against, and no votes are abstaining. Thank you.
Morten Opstad
executiveThank you, [ Freddie ]. Then we move to agenda item #8, which is an authorization to the Board for the company to acquire its own shares. It has also been a standard agenda item on the AGMs. We have not yet used that authorization, but the Board is still opting for similar authorization as previous years and it's limited to 10% of the registered share capital at the time of this notice. So I think we just move to voting on an agenda item #8 as well. So please cast your votes on agenda item #8. [Voting]
Unknown Attendee
attendeeAnd we have received the results, and closed the voting. 99.999% are in favor of the proposal. There are 12,409 shares voting against, and no votes abstaining. Thank you.
Morten Opstad
executiveThank you, [ Freddie ]. Then we are at agenda Item #9. And now we are on the agenda items, which is part of the proposal from the nomination committee, and that was submitted to the market yesterday morning and the committee, that is 3 persons. It's Mr. Robert Keith, who is Chair of the company; Håvard Nilsson is a member of the Audit [indiscernible] Nomination Committee; and Harald Voigt is the third member of the Nomination Committee. And the proposal with respect to agenda item #9, 9.1, and that is a board remuneration, which according to the proposal is an amount of NOK 495,000 for each board member, and then there is an additional amount to the Chair of the Board of NOK 85,000. Each of the compensation committee members will receive NOK 85,000. And the Chair of the Compensation Committee will receive an amount of NOK 125,000, while the audit committee members will receive NOK 100,000 and the Chair will receive NOK 175,000. So that is the same amount as last year, and I assume actually also the same amount as the year before that. And in addition, under 9.2 , there is a proposal with an authorization for the Board members to then take this remuneration in shares instead of cash payment. So has there been any questions with respect to 9.1 and 9.2. If that's not the case, then we can have the vote on 9 1 and 9.2 at the same time. So please cast your votes. [Voting]
Unknown Attendee
attendeeAnd we have received the votes. 9.1, we have 84.85% in favor of the proposal, 15.15% are voting against, and no shares are abstaining. 9.2, we have 98.71% in favor of the proposal, 1.29% are voting against, and no shares are abstaining. Thank you.
Morten Opstad
executiveThank you, [ Freddie ]. And then we are moving to agenda item #10, where I will present also the proposal from the nomination committee. There are some changes at the Board, whereby Ms. Hanne Høvding, who has been at the Board for 16 years, she's stepping down, and Tom Quindlen will do the same, and we will -- thanks to both of them for their valuable services to the company for several years. Then the Board will be reduced from 7 to 6 members. Deputy Chair, Larry Ciaccia will now take the position as Chair of the Board. Morten Opstad will continue at the Board, and we have one new board member, Ms. Adriana Saitta, who is an experienced director with in-depth knowledge of the sector in which IDEX operates. And in the proposal, you can see a presentation of Ms. Adriana Saitta. And in addition, then also, Mr. Stephen Andrew Skaggs will continue and Deborah Lee Davis will continue. And as it is stated in the nomination committee proposal, they are in a process to recruit also a new senior executive from one of the larger payment networks to become a new Director of the company, but that will be at the next general meeting of the company. So the proposal is standard that Mr. Larry Ciaccia is elected as Chair of the Board for 2 years. And Deborah Davis, Ms. Annika Olsson and Morten Opstad, Adriana Saitta and Stephen Skaggs are elected a Board member for a period of 2 years. So that is the concrete proposal. So I think you then vote on that proposal that is, again, items #10. So please cast your votes. [Voting]
Unknown Attendee
attendeeAnd we have received the votes and closed the voting. The results on agenda Item #10 is 85.04% in favor of the proposal, 14.96% against, and no votes abstaining. Thank you.
Morten Opstad
executiveThank you, [ Freddie ]. Agenda item #11, that is remuneration of the nomination committee, and that is also similar to what it has been in previous years, and that is NOK 35,000 to the Chair of the committee and NOK 15,000 to each of the members of the committee for the period from last year meeting to this general meeting. So please cast your votes on agenda item #11. [Voting]
Unknown Attendee
attendeeAnd voting is closed. We have received on agenda item #11, 85.74% in the favor of the proposal, 14.96% against and no votes abstaining.
Morten Opstad
executiveThank you. Last agenda item from the nomination committee that is agenda item #12, which is election of the nomination committee, and the proposal is that Mr. Rob Keith is elected for a period of 2 years, that Mr. Harald Voigt is also reelected as a member for a period of 2 years and that Mr. Håvard Nilsson continues as a member of the nomination committee for the second year of his term. So let's also then move to voting on agenda item #12. Please cast your votes. [Voting]
Unknown Attendee
attendeeAnd we have closed the voting. Results on agenda item #12 is 98.71% in favor of the proposal, 1.29% against and no votes abstaining.
Morten Opstad
executiveThank you. And finally, the last agenda item at today's Annual General Meeting, and that is a resolution of the remuneration of the auditor, where the proposal is that the general meeting approves payment of the auditor fees for 2022 against invoice and I think note 18 in the consolidated financial statements will view the specific amounts to the auditor. So the proposal is to pay our auditor according to the invoice. So please cast your votes. [Voting]
Unknown Attendee
attendeeAnd we have now finally closed the voting on this last agenda item. We have received 100% in favor of the proposal, agenda item #13, no votes against and no votes abstaining. Thank you.
Morten Opstad
executiveThank you, [ Freddie ]. I know that -- that is the last agenda item. I know that we have a couple of questions from one of the shareholders that are not related to the general meeting as such. I think it's a question related to our CEO. I can read the questions, but can they be put on the -- okay. But it's connected to actually -- it's connected to -- its commercial questions. And my proposal will actually be -- so those attending the meeting will see the questions now. It's relating to what we have in stock and what we can do with [ sensors ] and stock and so on. My proposal will be that our IR contact, Marianne Bøe will connect with Mr. [indiscernible] and answer those questions. And maybe also Vince can do that. But we have no presentation on the commercial side as part of the general meeting. It has been a presentation at [ Arctic ] earlier today. So I think it's better for them to answer those questions directly to [ Mr. Siva ], either by email or giving him a call. Are there any other questions coming up from the attending shareholders. If that's not the case, then conclude the meeting, and thank you for attending this Annual General Meeting of IDEX this year. Thank you so much, and then we close the meeting.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete IDEX Biometrics ASA transcript — plus 251,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to IDEX Biometrics ASA earnings transcripts and 251,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.